BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 14744620)

  • 1. Azithromycin reverses anticancer drug resistance and modifies hepatobiliary excretion of doxorubicin in rats.
    Asakura E; Nakayama H; Sugie M; Zhao YL; Nadai M; Kitaichi K; Shimizu A; Miyoshi M; Takagi K; Takagi K; Hasegawa T
    Eur J Pharmacol; 2004 Jan; 484(2-3):333-9. PubMed ID: 14744620
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Involvement of the drug transporters p glycoprotein and multidrug resistance-associated protein Mrp2 in telithromycin transport.
    Yamaguchi S; Zhao YL; Nadai M; Yoshizumi H; Cen X; Torita S; Takagi K; Takagi K; Hasegawa T
    Antimicrob Agents Chemother; 2006 Jan; 50(1):80-7. PubMed ID: 16377671
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Possible involvement of the drug transporters P glycoprotein and multidrug resistance-associated protein Mrp2 in disposition of azithromycin.
    Sugie M; Asakura E; Zhao YL; Torita S; Nadai M; Baba K; Kitaichi K; Takagi K; Takagi K; Hasegawa T
    Antimicrob Agents Chemother; 2004 Mar; 48(3):809-14. PubMed ID: 14982769
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of multidrug resistance modulators on the hepatobiliary disposition of doxorubicin in the isolated perfused rat liver.
    Booth CL; Brouwer KR; Brouwer KL
    Cancer Res; 1998 Aug; 58(16):3641-8. PubMed ID: 9721873
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gender-related differences in expression and function of hepatic P-glycoprotein and multidrug resistance-associated protein (Mrp2) in rats.
    Suzuki T; Zhao YL; Nadai M; Naruhashi K; Shimizu A; Takagi K; Takagi K; Hasegawa T
    Life Sci; 2006 Jun; 79(5):455-61. PubMed ID: 16483613
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Shiga-like toxin II impairs hepatobiliary transport of doxorubicin in rats by down-regulation of hepatic P glycoprotein and multidrug resistance-associated protein Mrp2.
    Hidemura K; Zhao YL; Ito K; Nakao A; Tatsumi Y; Kanazawa H; Takagi K; Ohta M; Hasegawa T
    Antimicrob Agents Chemother; 2003 May; 47(5):1636-42. PubMed ID: 12709333
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibitory effect of erythromycin on P-glycoprotein-mediated biliary excretion of doxorubicin in rats.
    Kiso S; Cai SH; Kitaichi K; Furui N; Takagi K; Takagi K; Nabeshima T; Hasegawa T
    Anticancer Res; 2000; 20(5A):2827-34. PubMed ID: 11062690
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of 17α-ethynylestradiol-induced cholestasis on the pharmacokinetics of doxorubicin in rats: reduced biliary excretion and hepatic metabolism of doxorubicin.
    Choi YH; Lee YK; Lee MG
    Xenobiotica; 2013 Oct; 43(10):901-7. PubMed ID: 23574017
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Possible involvement of P-glycoprotein in renal excretion of pazufloxacin in rats.
    Shimizu A; Miyoshi M; Sugie M; Ueyama J; Yamaguchi T; Sasaki T; Takagi K; Jin M; Miyamoto K; Tsuji A; Hasegawa T
    Eur J Pharmacol; 2004 Oct; 501(1-3):151-9. PubMed ID: 15464074
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Possible involvement of P-glycoprotein in the biliary excretion of grepafloxacin.
    Zhao YL; Cai SH; Wang L; Kitaichi K; Tatsumi Y; Nadai M; Yoshizumi H; Takagi K; Takagi K; Hasegawa T
    Clin Exp Pharmacol Physiol; 2002 Mar; 29(3):167-72. PubMed ID: 11906478
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Involvement of multidrug resistance-associated protein 2 (ABCC2/Mrp2) in biliary excretion of micafungin in rats.
    Abe F; Ueyama J; Kimata A; Kato M; Hayashi T; Nadai M; Saito H; Takeyama N; Noguchi H; Hasegawa T
    Life Sci; 2008 Aug; 83(7-8):229-35. PubMed ID: 18638490
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Correlation between reversing effect of cepharanthine hydrochloride on multidrug resistance and P-glycoprotein expression and function of K562/ADR cells].
    Peng YM; Wang N; Wang YF; Han L; Zhang Y; Jiang JH; Zhou YB; Wang QD
    Yao Xue Xue Bao; 2012 May; 47(5):594-9. PubMed ID: 22812001
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increase in bile flow and biliary excretion of glutathione-derived sulfhydryls in rats by drug-metabolizing enzyme inducers is mediated by multidrug resistance protein 2.
    Johnson DR; Habeebu SS; Klaassen CD
    Toxicol Sci; 2002 Mar; 66(1):16-26. PubMed ID: 11861969
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reversal of P-glycoprotein-mediated multidrug resistance by guggulsterone in doxorubicin-resistant human myelogenous leukemia (K562/DOX) cells.
    Xu HB; Li L; Liu GQ
    Pharmazie; 2009 Oct; 64(10):660-5. PubMed ID: 19947169
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ticlopidine, a cholestatic liver injury-inducible drug, causes dysfunction of bile formation via diminished biliary secretion of phospholipids: involvement of biliary-excreted glutathione-conjugated ticlopidine metabolites.
    Yoshikado T; Takada T; Yamamoto H; Tan JK; Ito K; Santa T; Suzuki H
    Mol Pharmacol; 2013 Feb; 83(2):552-62. PubMed ID: 23220748
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reversal effect of a macrocyclic bisbibenzyl plagiochin E on multidrug resistance in adriamycin-resistant K562/A02 cells.
    Shi YQ; Qu XJ; Liao YX; Xie CF; Cheng YN; Li S; Lou HX
    Eur J Pharmacol; 2008 Apr; 584(1):66-71. PubMed ID: 18304528
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recommendation to Exclude Bile-Duct-Cannulated Rats with Hyperbilirubinemia for Proper Conduct of Biliary Drug Excretion Studies.
    Kato K; Hasegawa Y; Iwata K; Ichikawa T; Yahara T; Tsuji S; Sugiura M; Yamaguchi J
    Drug Metab Dispos; 2016 Aug; 44(8):1180-3. PubMed ID: 27208382
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting P-Glycoprotein: Nelfinavir Reverses Adriamycin Resistance in K562/ADR Cells.
    Liu W; Meng Q; Sun Y; Wang C; Huo X; Liu Z; Sun P; Sun H; Ma X; Liu K
    Cell Physiol Biochem; 2018; 51(4):1616-1631. PubMed ID: 30497065
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kinetic analysis of hepatobiliary transport of vincristine in perfused rat liver. Possible roles of P-glycoprotein in biliary excretion of vincristine.
    Watanabe T; Miyauchi S; Sawada Y; Iga T; Hanano M; Inaba M; Sugiyama Y
    J Hepatol; 1992 Sep; 16(1-2):77-88. PubMed ID: 1362433
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Involvement of multidrug resistance-associated protein 2 (Abcc2) in molecular weight-dependent biliary excretion of beta-lactam antibiotics.
    Kato Y; Takahara S; Kato S; Kubo Y; Sai Y; Tamai I; Yabuuchi H; Tsuji A
    Drug Metab Dispos; 2008 Jun; 36(6):1088-96. PubMed ID: 18339814
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.